COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,142 Articles (22,693 medRxiv, 8,449 bioRxiv)

Most recent first Previous |  Page 3: Articles 21-30  | Next

Fragment-Based Development of NSP14 Exonuclease Inhibitors Confounded by Batch-to-Batch Variability
Coker, J. A., Sun, R., Polzer, P. M., Romigh, T., Goins, C. M., Wang, N. S., Jung, J. U., Stauffer, S. R.
10.1101/2025.11.21.689747 — Posted: 2025-11-24
Key residues in SARS-CoV-2 NSP3 hyper variable region are necessary to modulate early stress granule activity.
Alvarado, R. E., Lokugamage, K. G., Garvanska, D., Estes, L. K., Ahearn, Y. P., McLeland, A., Moayyed, A., Lopez-Mendez, B. D., Plante, J. A., Plante, K. S., Johnson, B. A., Nilsson, J. S., Menachery, V. D.
10.1101/2025.11.22.689758 — Posted: 2025-11-24
Deconvolving SARS-CoV-2 mRNA vaccine impact on immunotherapy-related survival in a pandemic
Jee, J., Zhang, J., Lavery, J., Waters, M., Fong, C., Minn, A., Glickman, M., Panageas, K., Sawyers, C., Schultz, N.
10.1101/2025.11.21.25340753 — Posted: 2025-11-23
Mental disorders, mortality following myocardial infarction and the impact of the COVID-19 pandemic in England: a cohort study
Fleetwood, K., Nolan, J., Berry, C., Cavers, D., Mercer, S. W., Padmanabhan, S., Smith, D. J., Stewart, R., Vettini, A., Jackson, C. A., CVD-COVID-UK/COVID-IMPACT Consortium
10.1101/2025.11.21.25340653 — Posted: 2025-11-22
Geoepidemiology of COVID-19 hospitalisations and severity: impact of social deprivation and remote areas, in the south-eastern Region, France
Garneret, P., Gaubert, G., Nauleau, S., Franke, F., Rebaudet, S., Mosnier, E., Canton, L., Schalkwijk, P., Chaud, P., Smaili, S., Vandentorren, S., Huart, M., Bendiane, M.-K., Landier, J., Gaudart, J.
10.1101/2025.11.17.25340377 — Posted: 2025-11-22
Reassessing the First Year of COVID-19: Estimating Infections and Tracking Pandemic Trends with Probabilistic Bias Analysis
Harkare, H. V.
10.1101/2025.11.21.25338950 — Posted: 2025-11-22
Mental disorders, receipt of acute cardiac care following myocardial infarction and the impact of the COVID-19 pandemic: a cohort study
Fleetwood, K., Nolan, J., Berry, C., Cavers, D., Mercer, S. W., Padmanabhan, S., Smith, D. J., Stewart, R., Vettini, A., Jackson, C. A., CVD-COVID-UK/COVID-IMPACT Consortium
10.1101/2025.11.21.25340556 — Posted: 2025-11-22
SARS-CoV-2 Evolution in an HIV-Endemic Setting: A Genomic Epidemiology Study from Botswana
Geng, X., Barilar, I., Kesamang, M., Tumedi, K. A., Matsheka, M., Modongo, C., Minin, V., Shin, S.
10.1101/2025.11.21.25340589 — Posted: 2025-11-22
Optimal biannual COVID-19 vaccine boosting dates for those aged 65 and over
Townsend, J. P., Hassler, H., Dornburg, A.
10.1101/2025.11.20.25340687 — Posted: 2025-11-21
Changing impact of COVID-19 vaccination on COVID-19 mortality in the SARS-CoV-2 omicron variant period, 2022-2025
Liu, B., Stepien, S., Macartney, K.
10.1101/2025.11.20.25340696 — Posted: 2025-11-21

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).